SCHEMBL7205324

SCHEMBL7205324

COc1nccc(C(=NO)C(=O)c2ccc(F)cc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.39
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
CYP1A2 P05177 2/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPK13 O15264 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
EGFR P00533 1/20 0.36
RAF1 P04049 1/20 0.36
LCK P06239 1/20 0.36
CYP2C9 P11712 1/20 0.36
PRKCA P17252 1/20 0.36
FRK P42685 1/20 0.36
MAPK9 P45984 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CSNK1D P48730 1/20 0.36
MAPK12 P53778 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7205226 0.85 CES1 (0.47) MAPK14CES2CES1CYP1A2CYP2D6
SCHEMBL4974273 0.80 ALDH1A1 (0.40) MAPK14CES2CES1CSNK1DKMT2A
SCHEMBL5605443 0.80 ALDH1A1 (0.40) MAPK14CES2CES1CSNK1DKMT2A
SCHEMBL4974278 0.80 ALDH1A1 (0.40) MAPK14CES2CES1CSNK1DKMT2A
SCHEMBL6159846 0.74 LTA4H (0.44) CES2CES1KMT2AL3MBTL1MEN1
SCHEMBL30443235 0.70 CES2 (0.62) CES2CES1CYP2C19KMT2AMAPT
SCHEMBL828659 0.70 CES2 (0.44) CES2CES1KMT2AL3MBTL1RAB9A
SCHEMBL828398 0.70 CES2 (0.44) CES2CES1KMT2AL3MBTL1RAB9A
SCHEMBL830162 0.70 CES2 (0.44) CES2CES1KMT2AL3MBTL1RAB9A
SCHEMBL17819925 0.69 ALDH1A1 (0.42) KDM4EKMT2AMAPTL3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6610695-B1 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease SMITHKLINE BEECHAM CORPORATION 2003-08-26 US disclosed
EP-0994870-A4 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM (US) 2002-10-23 EP disclosed
EP-0994870-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS Smithkline Beecham (US) 2000-04-26 EP disclosed
WO-1998057966-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1998-12-23 WO disclosed